Sling Therapeutics Alternatives & Competitors
12 companies similar to Sling Therapeutics — Focused on late-stage development of an oral small molecule for the treatment of...
Companies similar to Sling Therapeutics
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
France
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
Rival Readout
Competing with Sling Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Emeryville, United States
Novaliq GmbH
Transforming Ocular Therapeutics
Heidelberg, Germany
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
About Sling Therapeutics
Sling Therapeutics, a clinical-stage company founded in 2020, is making significant strides in the biopharma and biotechnology industries. The company is headquartered in the United States and focuses on the late-stage development of an oral small molecule designed to treat thyroid eye disease (TED). With a mission enc...
Development of Linsitinib for Thyroid Eye Disease, Conducting Clinical Trials, Therapeutic Pipeline Development, Medical Research and Innovation
Patients with Thyroid Eye Disease, Caregivers, Healthcare Providers, Medical Researchers
Thyroid Eye Disease, Biopharmaceutical, Clinical-stage Development, Oral Small Molecule, Drug Development, Autoimmune Diseases, Endocrinology, Ophthalmology, Hyperthyroidism, Clinical Research, Molecular Engineering, Chemistry, Patient Advocacy, Graves' Disease
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Sling Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Sling Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
